Prairie Doc Perspective Week of October 20th, 2024

The saying goes, "newer isn't always better," and while I typically tend to agree with that, newer might be better when it comes to glucose monitoring technology. In recent years we have seen rapid development and uptake of new types of glucometers, leaving fewer and fewer patients with diabetes using the old standby fingerstick method of blood sugar monitoring.

Let me be clear: not every patient with diabetes needs a fancy new continuous glucometer (CGM). The cost might be higher, and there is certainly more data to sort through with a continuous glucometer. So who stands to benefit the most?...